leadf
logo-loader
viewNovavax, Inc.

Novavax to present on COVID-19 vaccine candidate this week

The company is attending the 2020 World Vaccine Congress Washington scheduled for this week

Novavax, Inc. - Novavax to present on COVID-19 vaccine candidate this week

Novavax Inc (NASDAQ:NVAX) announced it will present on its lead COVID-19 vaccine candidate at the 2020 World Vaccine Congress Washington scheduled for this week.

It will also present its influenza and respiratory syncytial virus jabs, while the main focus will be to share expertise and the latest research related to the pandemic and vaccine development to address global health.

READ: Novavax to start late-stage trials for COVID-19 vaccine in UK

The US firm is set to start late-stage trials for NVX-CoV2373 in the UK, enrolling up to 10,000 participants aged 18-84 over the next six weeks, with half receiving the formulation and half receiving a placebo.

Up to 400 volunteers will receive both Novavax’s candidate and a seasonal flu vaccine to see if the combination works.

Data for from the Phase II of clinical trials are expected in the fourth quarter of 2020.

There are five pharma giants currently at the latest stage of trials for their COVID-19 vaccine candidates: Novavax, Johnson & Johnson, AstraZeneca, Pfizer and Moderna.

J&J said last week a single dose of its formulation produced a strong immune response in phase II of trials.

Quick facts: Novavax, Inc.

Price: 91.16 USD

NASDAQ:NVAX
Market: NASDAQ
Market Cap: $5.59 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Emperor Energy welcomes strong support for SPP as it progresses with Judith...

Emperor Energy Ltd's (ASX:EMP) Carl Dumbrell joins Proactive's Andrew Scott soon after receiving firm commitments to raise $656,000 through its share purchase plan (SPP) – attracting more than double the minimum $300,000 target. Net proceeds will go towards strengthening the company’s balance...

9 hours, 28 minutes ago

2 min read